News
The medical app market was worth $489 million in 2015 and nearly 40 percent of sales came from health monitoring apps, according to a report from research firm Kalorama Information.
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.
Some 21 percent of US adults use a wearable device right now, and of those, 36 percent use a Fitbit device, according to a Forrester Research survey of 952 online US adults.
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Sharing economy lodging giant Airbnb has acquired Lapka, a Russian startup, that developed smartphone-connected sensor offerings, including a smartphone-connected breathalyzer.
Like all populations, the population of seniors in the United States is changing.
The Icahn School of Medicine at Mount Sinai and LifeMap Solutions have updated the asthma app, called Asthma Health, that they created for ResearchKit, Apple's open source platform that helps researchers build medical apps and recruit patients for clinical trials.
Humana has partnered with Kurbo Health, which offers a mobile-enabled program aimed at preventing childhood obesity, to offer its employer customers the option to add a 12-month subscription of Kurbo Health as a wellness benefit for their employees.
Medtronic has launched its MiniMed Connect system, which allows people with diabetes who use both a Medtronic continuous glucose monitor (CGM) and a Medtronic insulin pump to see data from both device on their smartphone, and send it to their caregiver.
The Texas office of the Attorney General weighed in on a motion to dismiss Teladoc's antitrust suit against the Texas State Medical Board on the grounds that there is, in fact, state supervision of the medical board which would make it a state agency under law and therefore immune to suit.